Bioverge, Inc. — Form C/A (Regulation Crowdfunding)
Bioverge, Inc. of San Francisco, CA filed a Form C/A (Regulation Crowdfunding) with the SEC on 2021-05-14. Target raise $10K, up to $1.1M. Offered through NetCapital Funding Portal Inc..
Offering
- Filed: 2021-05-14
- Form: C/A
- Accession: 0001669191-21-000528
- Target amount: $10K
- Maximum amount: $1.1M
- Security type: Common Stock
- Securities offered: 8,772
- Price: $1.1400
- Deadline: 2021-06-29
- Funding portal / intermediary: NetCapital Funding Portal Inc.
- Intermediary file number: 007-00035
- Intermediary CRD: 283596
Issuer
- CIK: 0001828649
- Website: https://bioverge.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2017-08-17
- Address: 237 Kearny Street, San Francisco, CA, 94108
- Employees: 2
Financials (as filed)
- Total assets (most recent): $976K
- Cash (most recent): $570K
- Revenue (most recent): $69K
- Revenue (prior): $24K
- Net income (most recent): $-433K
- Net income (prior): $-161K
- Short-term debt: $124K
- Long-term debt: $1.4M
People (7)
| Name | Role | Location |
|---|
| Neil Littman | Board Member | San Francisco, CA |
| Neil Littman | Chief Executive Officer | San Francisco, CA |
| Neil Littman | President and CEO | San Francisco, CA |
| Neil Littman | Principal Accounting Officer | San Francisco, CA |
| Neil Littman | Principal Executive Officer | San Francisco, CA |
| Neil Littman | Principal Financial Officer | San Francisco, CA |
| Richard Gibb | COO | San Francisco, CA |
Reg CF filing history (14)
More